Literature DB >> 16990773

Quantitative RT-PCR analysis of sphingolipid metabolic enzymes in acute leukemia and myelodysplastic syndromes.

S Sobue, T Iwasaki, C Sugisaki, K Nagata, R Kikuchi, M Murakami, A Takagi, T Kojima, Y Banno, Y Akao, Y Nozawa, R Kannagi, M Suzuki, A Abe, T Naoe, T Murate.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16990773     DOI： 10.1038/sj.leu.2404386

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  27 in total

Review 1.  Evolving concepts in cancer therapy through targeting sphingolipid metabolism.

Authors:  Jean-Philip Truman; Mónica García-Barros; Lina M Obeid; Yusuf A Hannun
Journal:  Biochim Biophys Acta       Date:  2013-12-30

2.  Sphingosine kinase 1 downregulation is required for adaptation to serine deprivation.

Authors:  Jean-Philip Truman; Christian F Ruiz; Magali Trayssac; Cungui Mao; Yusuf A Hannun; Lina M Obeid
Journal:  FASEB J       Date:  2021-02       Impact factor: 5.191

3.  Resveratrol induces apoptosis of leukemia cell line K562 by modulation of sphingosine kinase-1 pathway.

Authors:  Hongying Tian; Zhongcui Yu
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

Review 4.  Targeting sphingosine-1-phosphate in hematologic malignancies.

Authors:  Christina E Stevenson; Kazuaki Takabe; Masayuki Nagahashi; Sheldon Milstien; Sarah Spiegel
Journal:  Anticancer Agents Med Chem       Date:  2011-11       Impact factor: 2.505

Review 5.  Development of small-molecule inhibitors of sphingosine-1-phosphate signaling.

Authors:  Yvette Edmonds; Sheldon Milstien; Sarah Spiegel
Journal:  Pharmacol Ther       Date:  2011-08-27       Impact factor: 12.310

6.  Development of SKI-349, a dual-targeted inhibitor of sphingosine kinase and microtubule polymerization.

Authors:  Jeremy A Hengst; Shailaja Hegde; Robert F Paulson; Jong K Yun
Journal:  Bioorg Med Chem Lett       Date:  2020-07-28       Impact factor: 2.823

7.  Implications of sphingosine kinase 1 expression level for the cellular sphingolipid rheostat: relevance as a marker for daunorubicin sensitivity of leukemia cells.

Authors:  S Sobue; S Nemoto; M Murakami; H Ito; A Kimura; S Gao; A Furuhata; A Takagi; T Kojima; M Nakamura; Y Ito; M Suzuki; Y Banno; Y Nozawa; T Murate
Journal:  Int J Hematol       Date:  2008-02-20       Impact factor: 2.490

8.  Withanolide D induces apoptosis in leukemia by targeting the activation of neutral sphingomyelinase-ceramide cascade mediated by synergistic activation of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase.

Authors:  Susmita Mondal; Chandan Mandal; Rajender Sangwan; Sarmila Chandra; Chitra Mandal
Journal:  Mol Cancer       Date:  2010-09-13       Impact factor: 27.401

Review 9.  Targeting SphK1 as a new strategy against cancer.

Authors:  Dai Shida; Kazuaki Takabe; Dmitri Kapitonov; Sheldon Milstien; Sarah Spiegel
Journal:  Curr Drug Targets       Date:  2008-08       Impact factor: 3.465

10.  Sphingosine kinase-1 is central to androgen-regulated prostate cancer growth and survival.

Authors:  Audrey Dayon; Leyre Brizuela; Claire Martin; Catherine Mazerolles; Nelly Pirot; Nicolas Doumerc; Leonor Nogueira; Muriel Golzio; Justin Teissié; Guy Serre; Pascal Rischmann; Bernard Malavaud; Olivier Cuvillier
Journal:  PLoS One       Date:  2009-11-26       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.